CHEMICAL/BIOLOGICAL DEFENSE (APPLIED RESEARCH)
Abstract
The projects in this program element (PE) support applied research in the areas of physical technologies, Non-Traditional Agent (NTA) medical and physical defense technologies, and medical technologies. Major efforts support development of vaccines, therapeutics, next generation diagnostics systems, next generation chemical detectors, nerve agent pretreatments, and individual protection advances. Individual projects include: - Chemical Biological Defense (CB2): continual improvements in CB physical sciences defense materiel, including contamination avoidance, decontamination, detection and protection technologies, as well as biological weapon/agent surveillance (e.g. CB protective materials, textiles, and filtration, sensors and sensing algorithms, effects modeling, chemical formulations, processes, and methods for hazard mitigation). - NTA Defense (NT2): supports all NTA efforts (both medical and non-medical) including pretreatments, therapeutics, detection, threat agent science, modeling, protection and hazard mitigation and characterization of emerging threats. Starting in FY21, a portion of the NTA lines have been merged into RDT&E Projects CB3, Chemical Biological Defense, and TM3, Techbase Medical Defense. The administrative change is intended to improve S&T budget agility and transition efficiency. - Techbase Medical Defense (TM2): development of antidotes, drug treatments, disease surveillance and point-of-need diagnostic devices, patient decontamination and medical technologies management (e.g. drug discovery and platform technology development, biomarkers and assay development useful in drug development and diagnostics, human mimicking devices and regulatory science). CBDP S&T Applied Research Stakeholders: U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC), United States Army Medical Research Institute of Infectious Diseases (USAMRIID), United States Army Medical Research Institute of Chemical Defense (USAMRICD), United States Army Natick Soldier Systems Center, Naval Research Lab (NRL), Air Force Research Lab (AFRL), among others. The intent is to maintain strategic partnerships with the Department of Defense (DoD) Service communities for mission success across the enterprise through collaborative planning and programming maintaining budget assurance. Efforts under this PE will transition to or will provide risk reduction for Advanced Technology Development (PE 0603384BP), Advanced Component Development and Prototypes (PE 0603884BP), and System Development and Demonstration (PE 0604384BP) activities.
Document Details
- Document Type
- R2 Budgetary Justification
- Publication Date
- Oct 01, 2022
- Source ID
- 0602384BP_2_0400_PB_2022
- Change Summary Explanation
- Funding: FY20 (-$8.501 Million): Internal Reprogramming (FY20-31 IR) for the Coronavirus Aid, Relief, and Economic Security (CARES) Act to conduct rapid assessments and characterizations of emerging pathogens (+$1.500 Million); below threshold reprogramming to Advanced Technology Development for COVID-19 SARS-CoV-2 vaccine development project (-$5.404 Million) and medical defense pretreatments efforts (-$3.909 Million); below threshold reprogramming to RDT&E Management Support for support to laboratory infrastructure for laboratory operations, facilities sustainment, and regulatory compliance for critical chemical biological defense activities at USAMRIID and USAMRICD (-$0.688 Million). FY20 (-$5.453 Million): Transfer of funding to support Small Business Innovative Research/Small Business Technology Transfer efforts. FY22: (-$1.679 Million): Program adjustments for Emerging Threat Rapid Response Capabilities (+$2.300 Million); Departmental reduction to account for the availability of prior year execution balances (-$1.931 Million); and Departmental inflation/travel adjustments (-$2.048 Million). Schedule: N/A Technical: N/A
- Service Agency Name
- Chemical and Biological Defense Program
Related Documents
- Child Project: Chemical Biological Defense (Applied Research)
- Child Accomplishment: 1) CARES Act: - ProBE: Proteomic/Multi-omic Biothreat Evaluation
- Child Accomplishment: 2) CARES Act: Reusable N95 Masks to DEVCOM CBC
- Child Accomplishment: 3) Internal COVID: Virus decon to DEVCOM CBC
- Child Accomplishment: 4) Internal COVID: Portable bio containment module testing at DEVCOM SC.
- Child Accomplishment: 5) Detection Sensor Technologies
- Child Accomplishment: 6) Distributed CB Reconnaissance
- Child Accomplishment: 7) Enhanced/Emerging Biothreat Sensing
- Child Accomplishment: 8) Expeditionary Analytical Toolkit (ExAnT)
- Child Accomplishment: 9) Unattended Perimeter Monitoring
- Child Accomplishment: 10) Unconventional Detection Modalities
- Child Accomplishment: 11) Material Contamination Mitigation
- Child Accomplishment: 12) Enhanced Survivability Coatings
- Child Accomplishment: 13) Equipment Decontamination
- Child Accomplishment: 14) Wide Area Decontamination
- Child Accomplishment: 15) Warning and Reporting
- Child Accomplishment: 16) CBRN Battlespace Surveillance, Alerting & Response
- Child Accomplishment: 17) Decision Analysis and Management
- Child Accomplishment: 18) CBRN Decision Aids
- Child Accomplishment: 19) CBRN Situational Awareness
- Child Accomplishment: 20) Threat Agent Sciences
- Child Accomplishment: 21) Employment Characterization
- Child Accomplishment: 22) Environmental Response
- Child Accomplishment: 23) First Look (Chemical and Biological)
- Child Accomplishment: 24) Host Response
- Child Accomplishment: 25) Technical Surprise
- Child Accomplishment: 26) Percutaneous Protection
- Child Accomplishment: 27) Dynamic Multifunction Materials for Second Skin
- Child Accomplishment: 28) Lightweight Protective Garments
- Child Accomplishment: 29) Respiratory and Ocular Protection
- Child Accomplishment: 30) All-Hazards & Respiratory Protection
- Child Accomplishment: 31) Multifunction Materials for Protection
- Child Accomplishment: 32) Personnel Contamination Mitigation
- Child Accomplishment: 33) Personnel Decontamination
- Child Accomplishment: 34) Expeditionary Collective Protection
- Child Accomplishment: 35) Air Purification Enhancements
- Child Project: Non-Traditional Agents Defense (Applied Research)
- Child Accomplishment: 1) Chemical Pretreatments and Prophylactics - Medical
- Child Accomplishment: 2) Chemical Therapeutics - Medical
- Child Accomplishment: 3) Expeditionary Collective Protection
- Child Accomplishment: 4) Material Contamination Mitigation
- Child Accomplishment: 5) Modeling & Simulation
- Child Accomplishment: 6) Percutaneous Protection
- Child Accomplishment: 7) Personnel Contamination Mitigation
- Child Accomplishment: 8) Respiratory and Ocular Protection
- Child Accomplishment: 9) Threat Agent Sciences
- Child Project: Techbase Medical Defense (Applied Research)
- Child Accomplishment: 1) Medical Diagnostics
- Child Accomplishment: 2) Chemical Diagnostics
- Child Accomplishment: 3) Diagnostic Building Blocks
- Child Accomplishment: 4) Emerging Threats
- Child Accomplishment: 5) Bacterial/Viral/Toxins/ Broad Spectrum Prophylaxis
- Child Accomplishment: 6) Chemical Therapeutics
- Child Accomplishment: 7) Chemical Reactive Ocular Wound and Dermal Therapeutics (CROWD)
- Child Accomplishment: 8) Enabling Science
- Child Accomplishment: 9) Pharmaceutical Based Agents (PBAs)
- Child Accomplishment: 10) Reactivators of AChE as Therapeutics (ReACT)
- Child Accomplishment: 11) Pretreatments and Prophylactics, Nerve Agents
- Child Accomplishment: 12) Bacterial Therapeutics
- Child Accomplishment: 13) Viral Therapeutics
- Child Accomplishment: 14) Toxin Therapeutics